Consultant thoracic and robotic surgeon
About this Event
About the Eric. M Flanders Lectureship
For over 30 years, the Eric M. Flanders Lectureship has brought leading lung cancer specialists from across the globe to McGill. These lectureships facilitated cross germination of new paradigms in patient care, research ideas, and clinical trainees between the visitor and the host institution, and without a doubt has had a profound and lasting impact on the care of those suffering from lung cancer not only here in Montreal, but across Canada.
In thoracic surgical oncology alone, three of our current attending surgeons thank their fellowship training to collaborative partnerships that originated during the Flanders Visiting Professorship in Lung Cancer.
This year we partner with TOEC!
The Thoracic Oncology Executive Committee (TOEC) is the governing body of the McGill Thoracic Oncology Program, aligned with the strategic orientation of the MUHC. Its key goals are to reduce delays, improve access to care for patients with lung cancer, and advance a world-class academic program integrating clinical care, education, and research. As part of this mandate, TOEC is evolving the lung cancer trajectory to better support and coordinate a network of partner organizations across the McGill network. TOEC brings together a multidisciplinary team, including patient partners, to collaboratively enhance patient-centered, evidence-informed care and strengthen quality and continuity across the care trajectory.
2026 Visiting Professor:
Mr Kelvin Lau is Clinical Director and consultant thoracic surgeon at St Bartholomew’s Hospital, London. He was appointed the first consultant thoracic surgeon there in 2013 to set up the thoracic surgery service. He has an interest in innovation and introduced VATS and then robotic surgery, and then with his team established the largest robotic thoracic surgery programme in the UK enabling them to achieve the highest minimally invasive and segmentectomy rates in the UK.
He has a strong interest in endoluminal approaches to the lung and established the first image-guided navigation bronchoscopy programme in Europe with cone beam CT. In 2018 he performed the first lung tumour therapeutic tumour destruction through bronchosopic microwave ablation and recently introduced robotic bronchoscopy to refine the ablation technique. He is principal investigator for NAVIGATE, NAVABLATE, MARS2 , ISI-Ion-EU1 and AURORA trials.
Event Venue & Nearby Stays
Montreal General Hospital, 1650 Avenue Cedar, Montréal, Canada
CAD 0.00
